Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Phathom Pharmaceuticals (PHAT) Return on Assets (2022 - 2025)

Phathom Pharmaceuticals (PHAT) has disclosed Return on Assets for 4 consecutive years, with 0.89% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Assets fell 1.0% to 0.89% in Q4 2025 year-over-year; TTM through Dec 2025 was 0.89%, a 1.0% decrease, with the full-year FY2025 number at 0.69%, up 15.0% from a year prior.
  • Return on Assets was 0.89% for Q4 2025 at Phathom Pharmaceuticals, up from 1.12% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.62% in Q4 2023 to a low of 1.26% in Q1 2023.
  • A 4-year average of 0.94% and a median of 0.9% in 2023 define the central range for Return on Assets.
  • Peak YoY movement for Return on Assets: soared 62bps in 2024, then plummeted -39bps in 2025.
  • Phathom Pharmaceuticals' Return on Assets stood at 1.08% in 2022, then surged by 43bps to 0.62% in 2023, then tumbled by -41bps to 0.87% in 2024, then decreased by -1bps to 0.89% in 2025.
  • Per Business Quant, the three most recent readings for PHAT's Return on Assets are 0.89% (Q4 2025), 1.12% (Q3 2025), and 1.21% (Q2 2025).